← Back to Search

Osteopathic Manipulative Treatment (OMT) for Coronavirus

N/A
Waitlist Available
Led By Jesus Sanchez, DO
Research Sponsored by Western University of Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial will test if adding osteopathic manipulative treatment to current mRNA COVID-19 vaccines can enhance the immune response.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
IgG antibody titer levels Percentage Change
IgM and IgG antibody titer duration
IgM antibody titer levels Percentage Change.
Secondary outcome measures
Adverse Effects/Side Effects
Medication Usage

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OMT Intervention ArmExperimental Treatment1 Intervention
OMT will include: Myofascial release of the thoracic inlet: gentle pressure applied to shoulders and neck to move the tissue in different directions with a gentle motion. Pectoral traction: The armpit will be contacted with the finger pads of the doctor and each side will be gently grasped and have a slow pulling force applied towards the shoulders. Diaphragm release with MFR: The doctor will touch below the ribs on each side and will apply gentle pressure and move the tissue from side to side. Splenic pump: below the ribs on the left hand-side, the doctor will apply pressure and release pressure several times to create a vibration over the area just below the ribs. Thoracic pump: The doctor will place their hands over the chest wall on each side and will apply pressure and release pressure several times to generate a pumping action of about 100 times in one minute. Treatment will last 5 minutes with each technique lasting 1 minute.
Group II: ControlActive Control1 Intervention
Participants in the control group will undergo the same assessments as the OMT intervention arm and will receive their vaccinations, but will not receive any OMT.

Find a Location

Who is running the clinical trial?

Western University of Health SciencesLead Sponsor
23 Previous Clinical Trials
1,263 Total Patients Enrolled
American College of Osteopathic PhysiciansUNKNOWN
American Osteopathic FoundationUNKNOWN
1 Previous Clinical Trials
20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment figure for this clinical trial?

"Affirmative. The clinicaltrials.gov website displays that this medical trial is still recruiting patients, having first been listed on June 11th 2021 and most recently updated on April 26th 2022. 200 individuals need to be enrolled from 1 site for the study to commence."

Answered by AI

Is eligibility for this medical experiment restricted to individuals younger than 50?

"To be eligible to join this research initiative, participants must lie between the age bracket of 18 to 65. There are a total of 138 trials for minors and 906 for elderly patients available."

Answered by AI

Is this research project open to new participants?

"Affirmative, the information hosted on clinicaltrials.gov reveals that this investigation is recruiting patients at present. This research was first posted in June 11th 2021 and has gone through its latest update April 26th 2022. 200 participants are needed to be recruited from 1 clinic site."

Answered by AI

Who is eligible to participate in this clinical trial?

"This trial, which will include a total of 200 patients, is available to those who are infected with covid19 and aged 18 to 65 years."

Answered by AI
~52 spots leftby Apr 2025